Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
12/2003
12/02/2003US6656718 Modified carboxypeptidase enzymes and their use
12/02/2003US6656717 Cyclic AMP phosphodiesterase isoforms and methods of use
12/02/2003US6656716 Polypeptide fragments of human PAK5 protein kinase
12/02/2003US6656715 Isolated nucleic acid encoding a polypeptide which catalyzes the oxidation of o-dianisidine; useful in replacing synthetic organic chemistry reactions to make active intermediates or products, such as pesticides and antibiotics
12/02/2003US6656713 Compounds and methods for modulating activation of NF-κB
12/02/2003US6656711 Fermentative preparation process for and crystal forms of cytostatics
12/02/2003US6656709 Methods of increasing the production of cobalamins using cob gene expression
12/02/2003US6656708 Splice variant; expression vectors
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656706 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
12/02/2003US6656705 Sciellin and uses thereof
12/02/2003US6656700 Isoforms of human pregnancy-associated protein-E
12/02/2003US6656681 Polycystic kidney disease 12 gene and uses thereof
12/02/2003US6656679 Heat shock protein-based vaccines and immunotherapies
12/02/2003US6656479 Protects a mammal against neosporosis
12/02/2003US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction
12/02/2003CA2085308C Dibasic endoprotease fused to endoplasmic reticulum retention signal and use thereof
12/02/2003CA2051562C Bacillus thuringiensis isolates active against dipteran pests
11/2003
11/27/2003WO2003097873A2 Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications
11/27/2003WO2003097871A2 Marker molecules associated with lung tumors
11/27/2003WO2003097856A2 Plating media
11/27/2003WO2003097853A2 Method of screening anti-bacterial agents for effectiveness in treating persistent intracellular infections
11/27/2003WO2003097846A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003WO2003097845A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
11/27/2003WO2003097838A1 Plasmid stabilisation in vivo
11/27/2003WO2003097825A2 Novel phospholipases and uses thereof
11/27/2003WO2003097821A1 Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide
11/27/2003WO2003097817A1 Novel microorganism acidovorax temperans and uses therefor
11/27/2003WO2003097816A1 Method of effecting lysis of acid-fast bacteria and method of performing gene amplification or detection therewith
11/27/2003WO2003097810A2 Nitrilases, nucleic acids encoding them and methods for making and using them
11/27/2003WO2003097798A2 Carotene synthase gene and uses therefor
11/27/2003WO2003097795A2 Constitutively translocating cell line
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003097091A2 Glucan-based vaccines
11/27/2003WO2003096969A2 Novel lambda phage display system and the process
11/27/2003WO2003096812A1 Regulated attenuation of live vaccines to enhance cross protective immunogenicity
11/27/2003WO2003080570A3 Recombinant expression vectors for functional nav1.9 sodium channels
11/27/2003WO2003078613A3 Serine hydroxymethyltransferase as a target for herbicides
11/27/2003WO2003078568A3 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
11/27/2003WO2003076469A3 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
11/27/2003WO2003075669A3 Food fermentation with lactic acid bacteria
11/27/2003WO2003072594A3 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
11/27/2003WO2003070765A3 Growth hormone fusion protein
11/27/2003WO2003068802A3 Materials and methods for preparing dimeric growth factors
11/27/2003WO2003066545A3 Amino acids factory
11/27/2003WO2003064622A3 Aggrecanase molecules
11/27/2003WO2003062270A3 Fluorescent protein from aequorea coerulscens and uses therof
11/27/2003WO2003056020A3 Expression vectors and promoters for heterologous gene expression
11/27/2003WO2003043986A3 Polypeptides of moraxella (branhamella) catarrhalis
11/27/2003WO2003042249A3 Peptide purification by means of metal ion affinity chromatography
11/27/2003WO2003036255A3 Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property
11/27/2003WO2003035696A3 Humanized antibodies against icam-1, their production and uses
11/27/2003WO2003034275A3 Chimeric glycosylphosphatidylinositol containing peptides
11/27/2003WO2003031578A3 Mammalian c-type lectins
11/27/2003WO2003030824A3 Methods and compositions for treating dermal lesions
11/27/2003WO2003029464A3 Genes associated with mast cell activation
11/27/2003WO2003027147A3 Human coagulation factor vii polypeptides
11/27/2003WO2003022868A3 Metal binding proteins and associated methods
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003018778A3 Method for preparing a freeze-dried composition containing lactic acid bacteria with enhanced bacterial viability and activity during storage at room temperature and resulting composition
11/27/2003WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes
11/27/2003WO2003016481A3 Novel human collagen proteins and polynucleotides encoding the same
11/27/2003WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
11/27/2003WO2003010195A3 Novel compounds
11/27/2003WO2002102299A3 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
11/27/2003WO2002097075B1 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
11/27/2003WO2002092801A3 Methods and compositions for making emamectin
11/27/2003WO2002092771A3 Specific binding proteins and uses thereof
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002074964A3 Polypeptides derived from rna polymerases and use thereof
11/27/2003WO2002072856A3 Improved process for converting nitriles to carboxylic acids using nitrilase
11/27/2003WO2002072838A3 A process for the fermentative preparation of d-pantothenic acid and/or its salts
11/27/2003WO2002072821A3 Method for indentification of cdnas encoding signal peptides
11/27/2003WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
11/27/2003WO2002068459A3 Non aggregating fluorescent proteins and methods for using the same
11/27/2003WO2002064791A3 Proteins and nucleic acids encoding same
11/27/2003WO2002064624A8 Improved method for production of secreted proteins in fungi
11/27/2003WO2002063010A3 Method of producing recombinant antibodies against tumors
11/27/2003WO2002061109A3 Yeast strains autonomously producing steroids
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002050113A3 Interleukin-1 related gene and protein
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003US20030221209 Modified proteinase inhibitors
11/27/2003US20030221205 Olfactory and pheromones G-protein coupled receptors
11/27/2003US20030220491 Novel human transporter proteins and polynucleotides encoding the same
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220488 Comprises peptide for diagnosing and treating cancer, hypoxia, blood and immunological disorders
11/27/2003US20030220484 Modified ciliary neurotrophic factors
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220472 Treatment of hematopoietic cell deficiencies, stimulating the production of hematopoietic cells, recombinant DNA sequence encodes or vector expression of the muteins; side effect reduction
11/27/2003US20030220405 DNA encoding an epsilon, epsilon-lycopene cyclase from romaine lettuce
11/27/2003US20030220379 Fermentative preparation process for and crystal forms of cytostatics
11/27/2003US20030220306 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
11/27/2003US20030220256 Truncated 24kDa basic fibroblast growth factor
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder
11/27/2003US20030219902 Methods and vectors for facilitating site-specific recombination